Cerecin, Inc.
44 Cook Street
Suite 100-71
Denver, CO 80206
Website: www.cerecin.com
Email: info@cerecin.com
Phone: (303) 999-3700

Number of Employees: 51-200



A CNS therapeutics company addressing unmet medical needs in brain health, including Alzheimer’s disease. Accera is focused on the clinical development of drugs with innovative mechanisms of actions. The company’s management team includes globally recognized specialists in central nervous system diseases and drug development, who together leverage the latest scientific knowledge and understanding of neurological disorders.

General Management
R&D/Regulatory
Drugs
Name Title Phone Email
Charles Stacey, MD President/CEO cstacey@accerapharma.com
Jerris Knaisch VP, Finance & NA Operations jerris.knaisch@accerapharma.com
Judy Walker, MD Chief Medical Officer
Samuel Henderson, PhD Chief Scientific Officer x702
Bruce Morimoto VP, Drug Development
General Management
Charles Stacey, MD President/CEO cstacey@accerapharma.com
Jerris Knaisch VP, Finance & NA Operations jerris.knaisch@accerapharma.com
R&D/Regulatory
Judy Walker, MD Chief Medical Officer
Samuel Henderson, PhD Chief Scientific Officer 702
Bruce Morimoto VP, Drug Development
AXONA ; Vitamins/minerals/supplements